Showing 1 - 14 results of 14 for search 'John Buscombe', query time: 0.02s Refine Results
  1. 1
    "When Was the Last Tiame You Do Something for the First Time" Part 2

    "When Was the Last Tiame You Do Something for the First Time" Part 2 by John Buscombe

    Published 2013-04-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Honour the Scientist

    Honour the Scientist by John Buscombe

    Published 2013-07-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Excellence is the enemy of good

    Excellence is the enemy of good by John Buscombe

    Published 2014-07-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Selective internal radiation therapy in metastatic carcinoma of the colon: A story of nonintegrated care?

    Selective internal radiation therapy in metastatic carcinoma of the colon: A story of nonintegrated care? by John Buscombe

    Published 2016-04-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Clinical Trials and Molecular Radiotherapy

    Clinical Trials and Molecular Radiotherapy by John Buscombe

    Published 2015-04-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Retraction: Multilocular disseminated tarlov cysts: Importance of imaging

    Retraction: Multilocular disseminated tarlov cysts: Importance of imaging by Prof. John Buscombe

    Published 2016-01-01
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Retraction: Development of 166 Holmium-1,2 Propylene Di-amino Tetra (Methy1enephosphonicacid) as a Possible Bone Palliation Agent

    Retraction: Development of 166 Holmium-1,2 Propylene Di-amino Tetra (Methy1enephosphonicacid) as a Possible Bone Palliation Agent by Prof. John Buscombe

    Published 2016-01-01
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Use of 18F FDG PET and the short temporal response of Hodgkin's disease to RIT

    Use of 18F FDG PET and the short temporal response of Hodgkin's disease to RIT by Ewa Nowosinska, Pei Chan, John Buscombe

    Published 2018-07-01
    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    Is there a Role for Gallium-67 Citrate SPECT/CT, in Patients with Renal Impairment or Who are Renal Transplant Recipients, in Identifying and Localizing Suspected Infection?

    Is there a Role for Gallium-67 Citrate SPECT/CT, in Patients with Renal Impairment or Who are Renal Transplant Recipients, in Identifying and Localizing Suspected Infection? by Ewa Nowosinska, Shaunak Navalkissoor, Ann Quigley, John Buscombe

    Published 2015-07-01
    Get full text
    Article
    Save to List
    Saved in:
  10. 10
    The Added Value of a Single-photon Emission Computed Tomography-Computed Tomography in Sentinel Lymph Node Mapping in Patients with Breast Cancer and Malignant Melanoma

    The Added Value of a Single-photon Emission Computed Tomography-Computed Tomography in Sentinel Lymph Node Mapping in Patients with Breast Cancer and Malignant Melanoma by George Bennie, Mariza Vorster, John Buscombe, Mike Sathekge

    Published 2015-01-01
    Get full text
    Article
    Save to List
    Saved in:
  11. 11
    Ensuring effective and sustainable radionuclide delivery and its impact on the development of nuclear medicine in the developing world with special reference to Nigeria

    Ensuring effective and sustainable radionuclide delivery and its impact on the development of nuclear medicine in the developing world with special reference to Nigeria by T. Akintunde Orunmuyi, M. Mike Sathekge, R. John Buscombe

    Published 2019-01-01
    Get full text
    Article
    Save to List
    Saved in:
  12. 12
    First results and experience with PRRT in South Africa

    First results and experience with PRRT in South Africa by Mariza Vorster, M Modiselle, C Corbett, I Lawal, John Buscombe, Mike Sathekge

    Published 2018-04-01
    Get full text
    Article
    Save to List
    Saved in:
  13. 13
    Quantifying the survival benefit of completing all the six cycles of radium-223 therapy in patients with castrate-resistant prostate cancer with predominant bone metastases

    Quantifying the survival benefit of completing all the six cycles of radium-223 therapy in patients with castrate-resistant prostate cancer with predominant bone metastases by John Buscombe, Daniel Gillett, Nick Bird, Anne Powell, Sarah Heard, Luigi Aloj

    Published 2021-04-01
    Get full text
    Article
    Save to List
    Saved in:
  14. 14
    Technetium-99m methylene diphosphonate single-photon emission computed tomography/computed tomography of the foot and ankle

    Technetium-99m methylene diphosphonate single-photon emission computed tomography/computed tomography of the foot and ankle by Bhavin Upadhyay, Jonathan Mo, Clare Beadsmoore, Tom Marshall, Andoni Toms, John Buscombe

    Published 2017-04-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: